This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Broadfield, L. Search for Related Content PubMed Articles by Broadfield, L. Social Bookmarking                         What's this?

Pharmaceutical care in oncology pharmacy practice: A method for using outcome indicators

Hamilton Regional Cancer Center, 699 Concession Street, Hamilton, Ontario, Canada

A method is discussed for design and implementation of a set of toxicity outcome indicators, linked to each chemotherapy protocol ordered for routine patient care. Pharmacists, as integral members of the systemic treatment team, participate in the monitoring of patient toxicities to chemotherapy, and the treatment and/or prevention of adverse effects. Rating scales vary from protocol to protocol, depending on the drugs in each specific protocol, and the unique toxicities associated with that combination of agents. Both objective and subjective toxicities are measured and monitored in a standardized format. Aside from assisting in the care of individual patients, these toxicity ratings may also be analyzed for various administrative purposes, including quality audit and planning of future services (including pharmaceutical care pro grams), and may be used for population-based descriptive research.

Key Words: Pharmaceutical care • outcomes, quality assurance • oncology pharmacy practice.

Journal of Oncology Pharmacy Practice, Vol. 1, No. 1, 9-14 (1995)
DOI: 10.1177/107815529500100101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?